The exosome diagnostic and therapeutic market is the point of interest in the liquid biopsy market as it is one of the emerging biomarker based procedures for the diagnosis of cancer.

Portland, OR -- (SBWire) -- 10/13/2017 --Increase in incidence and prevalence of cancer, growth in investments and initiatives implemented by the government and non-government associations around the world are the factors that majorly drive the growth of this market. The technological advancements for easy exosome isolation and advanced exosome based products for new applications also support the growth of the world exosome diagnostic and therapeutic market.
Exosome Diagnostic and Therapeutic Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $367 million by 2022, registering a CAGR of 37.8% during the period 2016-2022. Diagnostic application segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period.

Get the sample copy of this report for free: Click Here

According to the experts from leading companies in operating in this market, increase in prevalence of cancer, technological advancements, and rising emphasis on early diagnosis of cancer are some of the major factors driving market growth.

Make a purchase enquiry: Click Here

The instrument segment held the leading position with over 50% market share of the world exosome diagnostic and therapeutic market in 2015, owing to their frequent use in healthcare facilities for the isolation of exosome and research procedures.

EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET KEY SEGMENT

BY APPLICATION

-Diagnostic
-Therapeutic

BY PRODUCT

-Instrument
-Reagent
-Software

BY END USER

-Cancer Institute
-Hospital
-Diagnostic Center
-Others